Cosmos Health Files Patent Application for Multiple Sclerosis Treatment

MT Newswires Live
2025/02/06

Cosmos Health (COSM) filed a patent application for a treatment for multiple sclerosis.

This milestone highlights the partnership with Cloudpharm and the National Hellenic Research Foundation, supported by the pharma patent expert team at NLO Group, Cosmos Health said Wednesday in a statement.

The patent is based on data from Cosmos Health's artificial intelligence-powered Cloudscreen drug repurposing platform.

"Recent findings by Cosmos Health have demonstrated the potential of a repurposed marketed drug for treating MS, with the inventors identifying a unique mechanism of action," according to the statement.

MS is an autoimmune disorder that affects the central nervous system.

Price: 0.7096, Change: +0.0096, Percent Change: +1.37

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10